Analyst Ratings for Humacyte (HUMA)
HUMA Rating Summary
HUMA Price Target Summary
- Highest: $25.00 (D. Boral Capital)
- Lowest: $1.00 (Piper Sandler)
- Average: $5.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$5.25 (+517.6%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$5.25 (+517.6%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/31/2026 | Benchmark » Updated 6/1/2026 |
Bruce D. Jackson | Downgrade | Speculative Buy (Buy) |
2.00 (1.00) |
0.57 (0.85) |
49.12% | Details |
| 8/27/2025 | Barclays » Updated 4/8/2026 |
Matt Miksic | New Coverage | Overweight (N/A) |
1.50 (3.50) |
1.50 (0.85) |
-43.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
